Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiota in Bronchiectasis (BISER-2)
NCT02315547Unknown
- Sponsor
- Guangzhou Institute of Respiratory Health
- Start
- Jan 2015
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Open-label trial in bronchiectasis, sponsored by Guangzhou Institute of Respiratory Health. Primary endpoint: Relative abundance, diversity and richness of microbiota taxa at 3 years. Status: unknown.
02
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT02315547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02315547.